Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
The New England journal of medicine 2018 09 25() doi 10.1056/NEJMoa1810865 Abstract BACKGROUND Standard first-line therapy for metastatic, squamous non-small-cell lung cancer (NSCLC) is platinum-based chemotherapy or...
Read More